Related Experiment Videos
Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer
1Laboratoire de Biochimie des Régulations Cellulaires Endocrines, INSERM Unite 244, DBMS, CEA, Grenoble, France.
Abstract:
Two different protein tyrosine kinases were detected in the cytosolic fraction of different human tumor tissues. After partial purification, the two enzymes, which were highly active in breast tumor tissues, were characterized. One of them, soluble tyrosine kinase-1 (STK-1), represents a soluble form of the c-Src protein, which is apparently underphosphorylated on its C-terminal tyrosine residue whereas the other (STK-2) is a 48-kDa protein tyrosine kinase (PTK), which is molecularly and functionally related to the C-terminal Src kinase (Csk). These two protein tyrosine kinases clearly exhibit a different substrate specificity, and are responsible for the high tyrosine kinase activity present in the cytosolic fraction of human breast cancer. In addition, it was observed that STK-1 and STK-2 are also expressed in the breast cancer cell line, CAL-51.
Insights
Two novel protein tyrosine kinases, STK-1 and STK-2, were identified in human breast tumors. These enzymes contribute to elevated tyrosine kinase activity in breast cancer, with potential roles in disease progression.
Area of Science:
- Biochemistry
- Oncology
Background:
- Protein tyrosine kinases (PTKs) play crucial roles in cellular signaling pathways.
- Dysregulation of PTKs is frequently observed in various human cancers, including breast cancer.
Purpose of the Study:
- To identify and characterize novel protein tyrosine kinases present in the cytosolic fraction of human breast tumor tissues.
- To elucidate the specific roles of these kinases in breast cancer.
Main Methods:
- Partial purification of protein tyrosine kinases from human breast tumor cytosolic fractions.
- Biochemical characterization of the purified enzymes, including substrate specificity analysis.
- Detection of enzyme expression in breast cancer cell lines.
Main Results:
- Two distinct protein tyrosine kinases, soluble tyrosine kinase-1 (STK-1) and STK-2, were detected and partially purified.
- STK-1 was identified as a soluble form of c-Src, while STK-2 is a 48-kDa PTK related to Csk.
- Both kinases exhibited high activity in breast tumor tissues and distinct substrate specificities.
- STK-1 and STK-2 were also found to be expressed in the CAL-51 breast cancer cell line.
Conclusions:
- STK-1 and STK-2 are key contributors to the heightened tyrosine kinase activity observed in human breast cancer cytosol.
- These kinases represent potential therapeutic targets for breast cancer treatment.
- Further investigation into the specific functions and regulation of STK-1 and STK-2 in breast cancer is warranted.